Reduced expression of vacuole membrane protein 1 affects the invasion capacity of tumor cells.

Autor: Sauermann, M.¹, Sahin, Ö¹, Sültmann, H¹, Hahne, F.¹, Blaszkiewicz, S.¹, Majety, M.¹, Zatloukal, K.², Füzesi, L.³, Poustka, A.¹, Wiemann, S.¹ s.wiemann@dkfz.de, Arlt, D.¹ d.arlt@dkfz.de

Publikováno v: Oncogene. 2/21/2008, Vol. 27 Issue 9, p1320-1326. 7p. 1 Color Photograph, 1 Diagram, 2 Graphs.

Efficient baseband implementation on an SDR platform.

Autor: Wen Xu, Richter, M., Sauermann, M., Capar, F., Grassmann, C.

Publikováno v: ITS Telecommunications (ITST), 2011 11th International Conference on; 2011, p794-799, 6p

Source-Level Timing Annotation and Simulation for a Heterogeneous Multiprocessor.

Autor: Meyerowitz, T., Sangiovanni-Vincentelli, A., Sauermann, M., Langen, D.

Publikováno v: 2008 Design, Automation & Test in Europe; 2008, p276-279, 4p

The role of the transmembrane protein Vmp1 in the formation of cell-cell contacts

Autor: Arlt, D., Sauermann, M., Sahin, Oe, Majety, M., Zatloukal, K., Fuezesi, L., Holger Sültmann, Wiemann, S., Poustka, A.

Publikováno v: ResearcherID

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::02ef2fad7c441bae73d0141d43e0a804
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=ORCID&SrcApp=OrcidOrg&DestLinkType=FullRecord&DestApp=WOS_CPL&KeyUT=WOS:000255316100108&KeyUID=WOS:000255316100108

HIV-1 subtype-specific drug resistance on dolutegravir-based antiretroviral therapy: protocol for a multicentre study (DTG RESIST).

Autor: Egger M; Institute of Social & Preventive Medicine, University of Bern, Bern, Switzerland matthias.egger@ispm.unibe.ch.; Centre for Infectious Disease Epidemiology and Research, University of Cape Town Faculty of Health Sciences, Cape Town, Western Cape, South Africa., Sauermann M; Institute of Social & Preventive Medicine, University of Bern, Bern, Switzerland., Loosli T; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Hossmann S; Institute of Social & Preventive Medicine, University of Bern, Bern, Switzerland., Riedo S; Institute of Social & Preventive Medicine, University of Bern, Bern, Switzerland., Beerenwinkel N; Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland., Jaquet A; National Institute for Health and Medical Research (INSERM) UMR 1219, Research Institute for Sustainable Development (IRD) EMR 271, Bordeaux Population Health Centre, University of Bordeaux, Bordeaux, France., Minga A; Centre Médical de Suivi des Donneurs de Sang, Abidjan, Côte d'Ivoire., Ross J; TREAT Asia/amfAR - The Foundation for AIDS Research, Bangkok, Thailand., Giandhari J; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), University of KwaZulu-Natal, Durban, South Africa., Kouyos RD; Department of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.; Institute of Medical Virology, University of Zurich, Zurich, Switzerland., Lessells R; KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), University of KwaZulu-Natal, Durban, South Africa.; Centre for the Aids Programme of Research in South Africa (CAPRISA), Durban, South Africa.

Publikováno v: BMJ open [BMJ Open] 2024 Aug 21; Vol. 14 (8), pp. e085819. Date of Electronic Publication: 2024 Aug 21.